Integris Composites, Inc., a global leader in armor protection for the world’s elite military and police, says the new rapid response armor system is a first in an emerging category of Situational Armor. LAS VEGAS, Jan. 21, 2025 /PRNewswire/ — In a departure from a three-decade tradition…
Month: January 2025
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ: BIOA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
Dinner for Two and Romantic Accommodations for two MONTEREY, Calif., Jan. 21, 2025 /PRNewswire/ — Valentine’s Day is fast approaching, and Cupid’s arrows are flying; it’s time to wrap up plans for the perfect Valentine’s Day celebration. Give your special someone the gift of a romantic…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. (“Atara” or the “Company”) (NASDAQ: ATRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Edison International (“Edison” or the “Company”) (NYSE: EIX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. (“Keros” or the “Company”) (NASDAQ: KROS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. (“4D” or the “Company”) (NASDAQ: FDMT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against MGP Ingredients, Inc. (“MGPI” or the “Company”) (NASDAQ: MGPI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NYSE: HII). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980,…
NEW YORK, Jan. 21, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between February 7, 2024 and November 24, 2024, both dates inclusive (the “Class Period”), of the important February…